Supplemental material
Perspective
Antibodies to watch in 2022
Hélène Kaplona Translational Medicine Department, Institut de Recherches Internationales Servier, Suresnes, France
https://orcid.org/0000-0002-5597-2195View further author information
https://orcid.org/0000-0002-5597-2195View further author information, Alicia Chenowethb St. John’s Institute of Dermatology, School of Basic & Medical Biosciences, King’s College London, London, UKhttps://orcid.org/0000-0002-2736-9268View further author information
https://orcid.org/0000-0002-2736-9268View further author information, Silvia Cresciolib St. John’s Institute of Dermatology, School of Basic & Medical Biosciences, King’s College London, London, UKhttps://orcid.org/0000-0002-1909-5957View further author information
https://orcid.org/0000-0002-1909-5957View further author information & Janice M. Reichertc The Antibody Society, Inc, Framingham, MA, USACorrespondence[email protected]
https://orcid.org/0000-0003-0400-1951View further author information
https://orcid.org/0000-0003-0400-1951View further author information